Chinese Journal of Stroke ›› 2020, Vol. 15 ›› Issue (02): 195-201.DOI: 10.3969/j.issn.1673-5765.2020.02.018
Previous Articles Next Articles
Received:
2019-10-13
Online:
2020-02-20
Published:
2020-02-20
周宏宇,索阅,陈玮琪,王拥军
通讯作者:
王拥军 yongjunwang@ncrcnd.org.cn
基金资助:
国家科技重大专项(2017ZX09304018)
国家自然科学基金项目(81901177)
ZHOU Hong-Yu, SUO Yue, CHEN Wei-Qi, WANG Yong-Jun. Progress of Ring Finger Protein 213 Gene-related Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2020, 15(02): 195-201.
周宏宇,索阅,陈玮琪,王拥军. RNF213 基因相关脑血管病研究进展[J]. 中国卒中杂志, 2020, 15(02): 195-201.
[1] CHIMOWITZ M,LYNN M,DERDEYN C,etal. Stenting versus aggressive medical therapy forintracranial arterial stenosis[J]. N Engl J Med,2011,11(365):993-1003.[2] KAMADA F,AOKI Y,NARISAWA A,et al. Agenome-wide association study identifies RNF213as the first moyamoya disease gene[J]. J Hum Genet,2011,56(1):34-40.[3] MIYAWAKI S,IMAI H,TAKAYANAGI S,etal. Identification of a genetic variant common tomoyamoya disease and intracranial major arterystenosis/occlusion[J]. Stroke,2012,43(12):3371-3374.[4] MORITO D,NISHIKAWA K,HOSEKI J,et al.Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase,whichdynamically changes its oligomeric state[J/OL].Sci Rep,2014,4:4442[2019-10-13]. https://doi.org/10.1038/srep04442.[5] JOAZEIRO C,WEISSMAN A. RING finger proteins:mediators of ubiquitin ligase activity[J]. Cell,2000,102(5):549-552.[6] SAUER R T,BAKER T A. AAA+ proteases:ATPfueledmachines of protein destruction[J]. Annu RevBiochem,2011,80:587-612.[7] LEE S,SOWA M E,WATANABE Y H,et al. Thestructure of ClpB:a molecular chaperone thatrescues proteins from an aggregated state[J]. Cell,2003,2(115):229-240.[8] SUZUKI J,TAKAKU A. Cerebrovascular“moyamoya”disease. Disease showing abnormalnet-like vessels in base of brain[J]. Arch Neurol,1969,20(3):288-299.[9] SCOTT R M,SMITH E R. Moyamoya disease andmoyamoya syndrome[J]. N Engl J Med,2009,360(12):1226-1237.[10] KURODA S,HOUKIN K. Moyamoya disease:current concepts and future perspectives[J]. LancetNeurol,2008,7(11):1056-1066.[11] MINEHARU Y,TAKENAKA K,YAMAKAWAH,et al. Inheritance pattern of familial moyamoyadisease:autosomal dominant mode and genomicimprinting[J]. J Neurol Neurosurg Psychiatry,2006,77(9):1025-1029.[12] LIU W,MORITO D,TAKASHIMA S,et al.Identification of RNF213 as a susceptibility genefor moyamoya disease and its possible role invascular development[J/OL]. PLoS One,2011,6(7):e22542[2019-10-13]. https://doi.org/10.1371/journal.pone.0022542.[13] WU Z,JIANG H,ZHANG L,et al. Molecularanalysis of RNF213 gene for moyamoya disease inthe Chinese Han population[J/OL]. PLoS One,2012,7(10):e48179[2019-10-13]. https://doi.org/10.1371/journal.pone.0048179.[14] MIYATAKE S,MIYAKE N,TOUHO H,et al.Homozygous c. 14576G>A variant of RNF213predicts early-onset and severe form of moyamoyadisease[J]. Neurology,2012,78(11):803-810.[15] CECCHI A C,GUO D,REN Z,et al. RNF213 rarevariants in an ethnically diverse population withmoyamoya disease[J]. Stroke,2014,45(11):3200-3207.[16] WANG Y,ZHAO X,LIU L,et al. Prevalence andoutcomes of symptomatic intracranial large arterystenoses and occlusions in China:the ChineseIntracranial Atherosclerosis(CICAS)Study[J].Stroke,2014,45(3):663-669.[17] PU Y,LIU L,WANG Y,et al. Geographic andsex difference in the distribution of intracranialatherosclerosis in China[J]. Stroke,2013,44(8):2109-2114.[18] OJHA R,HUANG D,AN H,et al. Distributionof ischemic infarction and stenosis of intra- andextracranial arteries in young Chinese patients withischemic stroke[J/OL]. BMC Cardiovasc Disord,2015,15:158[2019-10-13]. https://doi.org/10.1186/s12872-015-0147-5.[19] PARK M G,SHIN J H,LEE S W,et al. RNF213rs112735431 polymorphism in intracranial arterysteno-occlusive disease and moyamoya disease inKoreans[J]. J Neurol Sci,2017,375:331-334.[20] XUE S,CHENG W,WANG W,et al. Theassociation between the ring finger protein 213gene R4810K variant and intracranial major arterystenosis/occlusion in the Han Chinese populationand high-resolution magnetic resonance imagingfindings[J]. Brain Circ,2018,4(1):33-39.[21] ZHANG T,GUO C,LIAO X,et al. Genetic analysisof RNF213 p. R4810K variant in non-moyamoyaintracranial artery stenosis/occlusion disease in aChinese population[J/OL]. Environ Health Prev Med,2017,22:41[2019-10-13]. https://doi.org/10.1186/s12199-017-0649-0.[22] ZHANG Q,YU L,GE P,et al. Association of ringfinger protein 213 gene p.R4810k polymorphismwith intracranial major artery stenosis/occlusion[J]. JStroke Cerebrovasc Dis,2018,27(6):1556-1564.[23] WANG W,JIANG B,SUN H,et al. Prevalence,incidence,and mortality of stroke in China:resultsfrom a nationwide population-based survey of480 687 adults[J]. Circulation,2017,8(135):759-771.[24] OKAZAKI S,MORIMOTO T,KAMATANIY,et al. Moyamoya disease susceptibility variantRNF213 p.R4810K increases the risk of ischemicstroke attributable to large-artery atherosclerosis[J].Circulation,2019,139(2):295-298.[25] KAMIMURA T,OKAZAKI S,MORIMOTO T,etal. Prevalence of RNF213 p.R4810K variant in earlyonsetstroke with intracranial arterial stenosis[J].Stroke,2019,50(6):1561-1563.[26] LIU Y,WU X,FAN Z,et al. Development ofatherosclerotic-moyamoya syndrome with geneticvariant of RNF213 p.R4810K and p.T1727M:a casereport[J]. Clin Neurol Neurosurg,2018,168:163-166.[27] FROSEN J. Smooth muscle cells and theformation,degeneration,and rupture of saccularintracranial aneurysm wall--a review of currentpathophysiological knowledge[J]. Transl Stroke Res,2014,5(3):347-356.[28] RUIGROK Y M,RINKEL G J. Genetics ofintracranial aneurysms[J]. Stroke,2008,39(3):1049-1055.[29] CARANCI F,BRIGANTI F,CIRILLO L,etal. Epidemiology and genetics of intracranialaneurysms[J]. Eur J Radiol,2013,82(10):1598-1605.[30] FUKUSHIMA Y,MIYAWAKI S,INOUE T,etal. Repeated de novo aneurysm formation afteranastomotic surgery:potential risk of genetic variantRNF213 c.14576G>A[J/OL]. Surg Neurol Int,2015,6:41[2019-10-13]. https://doi.org/10.4103/2152-7806.153709.[31] ZHOU S,AMBALAVANAN A,ROCHEFORTD,et al. RNF213 is associated with intracranialaneurysms in the French-Canadian population[J].Am J Hum Genet,2016,99(5):1072-1085.[32] HITOMI T,HABU T,KOBAYASHI H,et al. Themoyamoya disease susceptibility variant RNF213R4810K(rs112735431)induces genomic instabilityby mitotic abnormality[J]. Biochem Biophys ResCommun,2013,439(4):419-426.[33] SONOBE S,FUJIMURA M,NIIZUMA K,et al.Temporal profile of the vascular anatomy evaluatedby 9.4-T magnetic resonance angiography andhistopathological analysis in mice lacking RNF213:a susceptibility gene for moyamoya disease[J]. BrainRes,2014,1552:64-71.[34] SONOBE S,FUJIMURA M,NIIZUMA K,etal. Increased vascular MMP-9 in mice lackingRNF213:moyamoya disease susceptibility gene[J].Neuroreport,2014,25(18):1442-1446.[35] ITO A,FUJIMURA M,NIIZUMA K,et al.Enhanced post-ischemic angiogenesis in micelacking RNF213;a susceptibility gene for moyamoyadisease[J]. Brain Res,2015,1594:310-320.[36] KONG Y W,FERLAND-MCCOLLOUGHD,JACKSON T J,et al. microRNAs in cancermanagement[J/OL]. Lancet Oncol,2012,13(6):e249-e258[2019-10-13]. https://doi.org/10.1016/S1470-2045(12)70073-6.[37] DAI D,LU Q,HUANG Q,et al. Serum miRNAsignature in Moyamoya disease[J/OL]. PLoS One,2014,9(8):e102382[2019-10-13]. https://doi.org/10.1371/journal.pone.0102382.[38] KOBAYASHI H,MATSUDA Y,HITOMI T,etal. Biochemical and functional characterizationof RNF213(mysterin)R4810K,a susceptibilitymutation of moyamoya disease,in angiogenesis invitro and in vivo[J/OL]. J Am Heart Assoc,2015,4(7):e002146[2019-10-13]. https://doi.org/10.1161/JAHA.115.002146.[39] OHKUBO K,SAKAI Y,INOUE H,et al.Moyamoya disease susceptibility gene RNF213 linksinflammatory and angiogenic signals in endothelialcells[J/OL]. Sci Rep,2015,5:13191[2019-10-13].https://doi.org/10.1038/srep13191. |
[1] | GUI Jinmin, XUE Rui, LI Na, LIU Qinglin, ZHAO Donghong. Individualized Management of Blood Pressure and Liquid Control for Moyamoya Patients with Hyperperfusion Syndrome after Extracranial-Intracranial Bypass [J]. Chinese Journal of Stroke, 2022, 17(12): 1350-1354. |
[2] | HAN Guangsong, NI Jun. Advances in Clinical Classification of Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(10): 1120-1126. |
[3] | FU Heguan, SHEN Xuxuan, XU Jiali, ZHANG Houdi, LI Bin, ZOU Zhengxing, FENG Jie, DUAN Lian, HAN Cong. The Types and Risk Factors of Stroke in Young Patients with Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(09): 937-943. |
[4] | KANG Shuai, HAN Heze, LU Junlin, CHEN Xiaolin, CHEN Yu, YE Xun, WANG Rong, ZHAO Yuanli. Incidence and Risk Factors of Non-infective Fever after Cerebral Revascularization in Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(07): 742-747. |
[5] | BAO Xiangyang, DUAN Lian. Cultivation and Teaching Experience of Postgraduates in Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(04): 426-428. |
[6] | ZHAO Dong-Hong, ZHANG Dong, XUE Rui, YUAN Qiao-Ling. Application of Personalized Cognitive Function Nursing and Training in Adult Patients with Moyamoya Diseaseafter Surgical Revascularization [J]. Chinese Journal of Stroke, 2021, 16(11): 1144-1149. |
[7] | DENG Qi-Le, WU Jie-Hong, CHEN Ji-Xiang. Progress of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in the Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(08): 850-854. |
[8] | SHA Ying, HE Jian,WANG Qing, XIE Qing, ZHANG Lei.. Effect of Nursing in Hyperbaric Oxygen in Children with Ischemic Moyamoya Disease [J]. Chinese Journal of Stroke, 2020, 15(07): 771-774. |
[9] | . Application Value of Arterial Spin Labeling in Evaluating Cerebral Perfusion and Collateral Circulation in Children Patients with Moyamoya Disease [J]. Chinese Journal of Stroke, 2020, 15(05): 537-543. |
[10] | ZENG Tao, XIAO Xuan-Hao, XU Bang-Lao, LEI Xiu-Xia, LI Ze, ZHOU Jin, HUANG Hui, PAN Xiao-Ping. Association of CYP2C19 Gene Polymorphisms with Risk of Recurrent Stroke in First-ever Ischemic Stroke Patients with Clopidogrel for Secondary Prevention [J]. Chinese Journal of Stroke, 2018, 13(09): 908-914. |
[11] | LIU Xing-Ju,KANG Shuai, ZHANG Dong, WANG Rong, ZHANG Yan, ZHANG Qian, ZHAO Ji-Zong. Study on Natural History of Adult Patients with Hemorrhagic Moyamoya Disease [J]. Chinese Journal of Stroke, 2017, 12(11): 995-999. |
[12] | WANG Jia,ZHANG Dong, WANG Rong, ZHAO Ji-Zong. Analysis of Influential Factors for Ischemic Stroke of Pediatric Moyamoya Disease [J]. Chinese Journal of Stroke, 2017, 12(09): 817-821. |
[13] | XU Man-Man, XU Yun. The Precision Diagnosis and Treatment of Intracranial Arterial Lesions with High-resolution Magnetic Resonance Imaging [J]. Chinese Journal of Stroke, 2017, 12(08): 720-724. |
[14] | ZHOU-Hao, WEI Shou-Chao, ZHAO Xing-Jun, et al.. Study on the Correlation between Polymorphism of 5,10 Methylenetetrahydrofolate Reductase Gene and Carotid Atherosclerosis in Patients with Cerebral Infarction [J]. Chinese Journal of Stroke, 2017, 12(01): 23-28. |
[15] | WANG Xia, DAI Wei. Effect Analysis and Risk Evaluation of Hyperbaric Oxygen Therapy on Hemorrhagic Moyamoya Disease in Adult [J]. Chinese Journal of Stroke, 2016, 11(12): 1019-1022. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||